Issuer Free Writing Prospectus dated July 29, 2021
Filed pursuant to Rule 433(d)
Registration Statement No. 333-238050
2.450% Senior Notes due 2028
2.625% Senior Notes due 2031
July 29, 2021
This Pricing Term Sheet dated July 29, 2021 to the Preliminary Prospectus Supplement (the “Preliminary Prospectus Supplement”) dated July 29, 2021 of Centene Corporation (the “Issuer”) is qualified in its entirety by reference to the Preliminary Prospectus Supplement. The information in this Pricing Term Sheet supplements the Preliminary Prospectus Supplement and supersedes the information in the Preliminary Prospectus Supplement to the extent it is inconsistent with the information in the Preliminary Prospectus Supplement. Capitalized terms used but not defined in this Pricing Term Sheet have the meanings assigned to such terms in the Preliminary Prospectus Supplement.
| Issuer: | Centene Corporation |
| Distribution: | SEC Registered Offering |
| Security Description: | 2.450% Senior Notes due 2028 (the “new 2028 notes”) | 2.625% Senior Notes due 2031 |
| Aggregate Principal Amount: | $500,000,000 (following the Expected Settlement Date, there will be an aggregate $2,300,000,000 outstanding of the Company’s 2.450% senior notes due 2028) | $1,300,000,000 |
| Gross Proceeds: | $504,375,000 (excluding accrued interest from July 1, 2021) | $1,300,000,000 |
| Maturity: | July 15, 2028 | August 1, 2031 |
| Coupon: | 2.450% | 2.625% |
| Yield to Maturity: | 2.310% | 2.625% |
| Offering Price: | 100.875% of the principal amount | 100.000% of principal amount |
| Interest Payment Dates: | January 15 and July 15, commencing January 15, 2022 | August 1 and February 1, commencing February 1, 2022 |
| Record Dates: | January 1 and July 1 | July 15 and January 15 |
Optional Redemption:
| | |
Make-Whole Call: | Prior to May 15, 2028 (2 months prior to the maturity date), at greater of par and make-whole at discount rate equal to the Treasury Rate plus 50 basis points, plus accrued and unpaid interest
| Prior to May 1, 2031 (3 months prior to the maturity date), at greater of par and make-whole at discount rate equal to the Treasury Rate plus 50 basis points, plus accrued and unpaid interest
|
| Par Call: | On or after May 15, 2028 (2 months prior to the maturity date), at par, plus accrued and unpaid interest
| On or after May 1, 2031 (3 months prior to the maturity date), at par, plus accrued and unpaid interest
|
| Change of Control: | Putable at 101% of aggregate principal amount plus accrued and unpaid interest | Putable at 101% of aggregate principal amount plus accrued and unpaid interest |
| Trade Date: | July 29, 2021 | July 29, 2021 |
| Expected Settlement Date:* | (T+10); August 12, 2021 | (T+10); August 12, 2021 |
| Use of Proceeds: | The Issuer intends to use the net proceeds of the offering of the notes, together with a portion of the proceeds from the Credit Facility Transactions (as defined in the Prospectus Supplement) and cash on hand to complete redemptions of its outstanding 5.375% Senior Notes due June 1, 2026, its 5.375% Senior Notes due August 15, 2026 and WellCare Health Plans, Inc.’s 5.375% Senior Notes due June 1, 2016, including all premiums, accrued interest and costs and expenses related to the note redemptions. Pending the application of the net proceeds of the offering for the foregoing purposes, net proceeds may be temporarily used for general corporate purposes. | The Issuer intends to use the net proceeds of the offering of the notes, together with a portion of the proceeds from the Credit Facility Transactions (as defined in the Prospectus Supplement) and cash on hand to complete redemptions of its outstanding 5.375% Senior Notes due June 1, 2026, its 5.375% Senior Notes due August 15, 2026 and WellCare Health Plans, Inc.’s 5.375% Senior Notes due June 1, 2016, including all premiums, accrued interest and costs and expenses related to the note redemptions. Pending the application of the net proceeds of the offering for the foregoing purposes, net proceeds may be temporarily used for general corporate purposes. |
| CUSIP / ISIN: | 15135BAY7 / US15135BAY74 | 15135BAZ4 / US15135BAZ40 |
| Issue Ratings (Moody’s/S&P/Fitch):** | Ba1 / BBB- / BB+ | Ba1 / BBB- / BB+ |
| Denominations/ Multiple: | Denominations of $2,000 and integral multiples of $1,000 in excess thereof | Denominations of $2,000 and integral multiples of $1,000 in excess thereof |
| Joint Bookrunning Managers: | J.P. Morgan Securities LLC Barclays Capital Inc. BofA Securities, Inc. Truist Securities, Inc. Wells Fargo Securities, LLC |
| | |
| Co-Managers: | Fifth Third Securities, Inc. U.S. Bancorp Investments, Inc. MUFG Securities Americas Inc. Regions Securities LLC PNC Capital Markets LLC Allen & Company LLC BMO Capital Markets Corp. Stifel, Nicolaus & Company, Incorporated CIBC World Markets Corp. |
*The Issuer expects that delivery of the notes will be made to investors on or about the tenth business day following the date of confirmation of orders with respect to the notes (this settlement cycle being referred to as “T+10”). Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in two business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes prior to the second business day before the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially will settle T+10, to specify an alternative settlement cycle at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes prior to their date of delivery hereunder should consult their own advisors.
**Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
The Issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus and prospectus supplement in that registration statement and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may obtain these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the prospectus supplement if you request them from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by calling +1 (866) 803-9204; from Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by email at Barclaysprospectus@broadridge.com, or by calling (888) 603-5847; from BofA Securities, Inc., NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte, NC 28255-0001, Attn: Prospectus Department or by email at dg.prospectus_requests@bofa.com; from Truist Securities by email at joshua.t.jones@truist.com; and from Wells Fargo Securities, LLC, 550 S. Tryon Street, 5th Floor, Charlotte, North Carolina 28202, Attention: Leveraged Syndicate.
This Pricing Term Sheet does not constitute an offer to sell, or a solicitation of an offer to buy any security in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.
Any legends, disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such legends, disclaimers or other notices have been automatically generated as a result of this communication having been sent via Bloomberg or another system.
